GR3030632T3 - Expression of bordetella pertactin antigens in pichia - Google Patents

Expression of bordetella pertactin antigens in pichia

Info

Publication number
GR3030632T3
GR3030632T3 GR990401718T GR990401718T GR3030632T3 GR 3030632 T3 GR3030632 T3 GR 3030632T3 GR 990401718 T GR990401718 T GR 990401718T GR 990401718 T GR990401718 T GR 990401718T GR 3030632 T3 GR3030632 T3 GR 3030632T3
Authority
GR
Greece
Prior art keywords
pichia
expression
antigens
bordetella
pertactin antigens
Prior art date
Application number
GR990401718T
Other languages
English (en)
Inventor
Jeffrey John Clare
Michael Anthony Romanos
Original Assignee
Medeva Pharma Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10673740&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3030632(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medeva Pharma Limited filed Critical Medeva Pharma Limited
Publication of GR3030632T3 publication Critical patent/GR3030632T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
GR990401718T 1990-04-02 1999-06-30 Expression of bordetella pertactin antigens in pichia GR3030632T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909007416A GB9007416D0 (en) 1990-04-02 1990-04-02 Expression of heterologous protein in yeast
PCT/GB1991/000487 WO1991015571A1 (en) 1990-04-02 1991-03-28 Expression of heterologous protein in yeast

Publications (1)

Publication Number Publication Date
GR3030632T3 true GR3030632T3 (en) 1999-10-29

Family

ID=10673740

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990401718T GR3030632T3 (en) 1990-04-02 1999-06-30 Expression of bordetella pertactin antigens in pichia

Country Status (12)

Country Link
EP (2) EP0905251A1 (el)
JP (1) JP3510624B2 (el)
AT (1) ATE180013T1 (el)
CA (1) CA2078858C (el)
DE (1) DE69131226T2 (el)
DK (1) DK0527752T3 (el)
ES (1) ES2133284T3 (el)
FI (1) FI104981B (el)
GB (1) GB9007416D0 (el)
GR (1) GR3030632T3 (el)
NO (1) NO310150B1 (el)
WO (1) WO1991015571A1 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
GB8910570D0 (en) 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
US6197548B1 (en) 1990-04-02 2001-03-06 Medeva Pharma Limited Transformed Pichia expressing the pertactin antigen
GB9007657D0 (en) 1990-04-04 1990-05-30 Connaught Lab Purification of a pertussis outer membrane protein(omp69)
GB9027901D0 (en) * 1990-12-21 1991-02-13 Wellcome Found Acellular vaccine
GB9106568D0 (en) * 1991-03-27 1991-05-15 Wellcome Found Recombinant antigen
US6444211B2 (en) 1991-04-03 2002-09-03 Connaught Laboratories, Inc. Purification of a pertussis outer membrane protein
GB9402832D0 (en) * 1994-02-15 1994-04-06 Smith Kline Beecham Biolog S A Novel process
ATE286511T1 (de) 1999-02-17 2005-01-15 Pfizer Prod Inc Fusionsproteine mit trägern welche eine doppelte immunantwort induzieren
ES2303833T3 (es) 2000-05-25 2008-09-01 Institut Pasteur Polipeptidos que contienen polimorfismos de las regiones repetidas de pertactina en bordetella pertussis, bordetella parapertussis y bordetella bronchiseptica, su uso en diagnostico y en composiciones inmunogenicas.
EP1174505A1 (en) * 2000-06-30 2002-01-23 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur (Poly)peptides for the preparation of vaccines against Bordetella pertussis and/or Bordetella parapertussis, vaccines based upon such (poly)peptides, and antibodies against such peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ228948A (en) * 1988-05-13 1991-06-25 Phillips Petroleum Co Hbv particles containing s and pre-s 2 proteins and recombinant processes for their production in yeast cells

Also Published As

Publication number Publication date
FI924368A (fi) 1992-09-29
GB9007416D0 (en) 1990-05-30
NO923781L (no) 1992-09-29
CA2078858A1 (en) 1991-10-03
EP0527752A1 (en) 1993-02-24
EP0527752B1 (en) 1999-05-12
ES2133284T3 (es) 1999-09-16
CA2078858C (en) 2001-05-15
DE69131226T2 (de) 1999-09-23
WO1991015571A1 (en) 1991-10-17
ATE180013T1 (de) 1999-05-15
JPH05505725A (ja) 1993-08-26
DE69131226D1 (de) 1999-06-17
EP0905251A1 (en) 1999-03-31
NO310150B1 (no) 2001-05-28
FI104981B (fi) 2000-05-15
NO923781D0 (no) 1992-09-29
JP3510624B2 (ja) 2004-03-29
DK0527752T3 (da) 1999-11-01
FI924368A0 (fi) 1992-09-29

Similar Documents

Publication Publication Date Title
CA2114015A1 (en) Recombinant antibodies for human therapy
HK118297A (en) Process cartridge and method of assembling the process cartridge
GR3030632T3 (en) Expression of bordetella pertactin antigens in pichia
EP0480762A3 (en) Novel bacillus thuringiensis isolates active against dipteran pests
DK0733069T3 (da) Oprensede Primat CTLA-8-antigener og beslægtede reagenser
GR3024489T3 (el)
EP0521842A3 (el)
GR3021608T3 (en) Soft toric contact lens
GR3018098T3 (en) A mutant of bacillus subtiles and a method of producing surfactin with the use of the mutant.
JPS55132439A (en) Flywheel type energy accumlator
EP0776972A4 (en) GENE ENCODING THE IgG-Fc-BINDING PROTEIN
AU8298991A (en) Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins
IE960874L (en) Macif protein, genes coding therefor, expression vectors¹containing said genes, and transformant cells containing¹said protein
EP0340170A3 (en) Process for the production of polypeptides
ZA927861B (en) Artificial standard and control sera, processes for the preparation thereof and the use thereof.
EP0591548A4 (en) Anti-hbs antibody gene and expression plasmid thereof
EP0350218A3 (en) Monoclonal antibodies recognizing gamma atrial natriuretic polypeptide, hybridomas producing such antibodies, and their preparation and use
WO1994021812A3 (en) Hepatitis b escape mutant specific binding molecules
GR3014977T3 (en) Monoclonal antibody against endothelin, hybridoma capable of producing the same and radioimmunoassay for endothelin by using the same.
EP0457498A3 (en) Bacillus thuringiensis genes encoding dipteran-active toxins
EP0480418A3 (en) Image reading device
EP0661541A3 (de) Verfahren zur Herstellung langzeitstabiler klarer Seren.
IT1234404B (it) Procedimento di produzione di astucci per occhiali con resine poliuretaniche.
EP0789031A3 (el)
IL104086A0 (en) Novel translational activating sequence